Mirae Asset Small Cap Fund Direct Growth NAV Slips 1.07% to ₹12.54 on 15 October; 1-Year Return at 10.21%

Key Takeaways:

• Mirae Asset Small Cap Fund Direct Growth recorded an exact NAV of ₹12.54 on 15 October 2026, declining 1.07% during the valuation day. 
• The scheme's one-year trailing return stood at 10.21%, while valid three- and five-year CAGRs are unavailable because the fund has not completed those periods. 
• Welspun Corp was the largest disclosed position at 2.86%, narrowly ahead of TREPS at 2.82%; TREPS is a money-market exposure rather than an equity holding. 

Mirae Asset Small Cap Fund Direct Growth recorded a NAV of ₹12.54 on 15 October 2026, declining 1.07% for the valuation day. The exact date and NAV were available on the 5paisa primary card, so the two-decimal precision displayed by that source has been retained. 

The scheme is comparatively new and has not completed a full three-year or five-year period. Accordingly, no three-year or five-year CAGR should be estimated or extrapolated from shorter-period or since-inception data. The 5paisa performance section reported a one-year trailing return of 10.21%, while the maximum-period return displayed was 14.94. 

The main scheme card listed fund size at approximately ₹5,819 crore, a Direct Growth expense ratio of 0.70%, minimum SIP of ₹99 and minimum lump-sum investment of ₹5,000. In the portfolio, Welspun Corp was the largest disclosed entry at 2.86%. TREPS followed at 2.82%, but it represents short-term liquidity exposure rather than a listed equity. Kirloskar Oil Engines accounted for 2.53%, Bluestone Jewellery for 2.33% and Dr Lal PathLabs for 2.30%. 

The five largest disclosed entries, including TREPS, represented 12.84% of the portfolio snapshot. Historical risk figures displayed by 5paisa included standard deviation of 5.41, beta of 0.78 and a Sharpe ratio of 0.58. Given the scheme's short operating history, longer-period CAGR fields should remain blank until the relevant periods have actually been completed. 

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.